Global Trust Asset Management, LLC Crispr Therapeutics Ag Transaction History
Global Trust Asset Management, LLC
- $266 Million
- Q3 2024
A detailed history of Global Trust Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 500 shares of CRSP stock, worth $25,380. This represents 0.01% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$25,380
Previous $27,000
14.81%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
510Shares Held
57.4MCall Options Held
1.74MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$399 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$381 Million3.35% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$160 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$160 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$141 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.96B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....